Podcast

Wireless Monitoring in Chronic Heart Failure

Use of a wireless implantable device to monitor patients with NYHA class III heart failure reduces hospitalization and improves heart failure management.

Part of a series of podcasts created by the editors of The Lancet in order to “discuss journal highlights, including interviews with authors of key articles to provide context and insight to advancements in medicine and health worldwide,” this installment features William Abraham, MD, discussing the article “Wireless Pulmonary Artery Haemodynamic Monitoring in Chronic Heart Failure: A Randomised Controlled Trial.” The article presented results from the CHAMPION study, which was designed to “evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects suffering from HF.”

Click here to access and download this third-party podcast resource.

Related Videos
What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Looking at This Year in Pulmonology: A Lungcast 2024 Recap
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
© 2025 MJH Life Sciences

All rights reserved.